Grindeks to Offer New Anti-Diabetic Drugs in 2022 to Georgian Consumers

The leading pharmaceutical manufacturer in the Baltic region, Grindeks, which has been operating on the Georgian market for sixteen years, will offer the latest generation of anti-diabetic drugs to Georgian consumers and increase the range of hospital medicines in Georgia this year.